UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
292.34
+2.69 (0.93%)
At close: Oct 24, 2025
UCB SA Employees
As of December 31, 2024, UCB SA had 9,378 total employees, including 9,052 full-time and 326 part-time employees. The number of employees increased by 295 or 3.25% compared to the previous year.
Employees
9,378
Change (1Y)
295
Growth (1Y)
3.25%
Revenue / Employee
$935,149
Profits / Employee
$181,895
Market Cap
53.13B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9,378 | 295 | 3.25% |
| Dec 31, 2023 | 9,083 | 380 | 4.37% |
| Dec 31, 2022 | 8,703 | 142 | 1.66% |
| Dec 31, 2021 | 8,561 | 190 | 2.27% |
| Dec 31, 2020 | 8,371 | 765 | 10.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
UCB SA News
- 5 days ago - United Community Banks, Inc. (UCB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - UCB Reports Strong Q3 Results with Significant Growth in Revenue and Loans - GuruFocus
- 5 days ago - United Community Banks Inc. Announces Rise In Q3 Bottom Line - Nasdaq
- 6 days ago - United Community Banks Inc (UCB) Q3 2025 Earnings Report Preview: What to Expect - GuruFocus
- 10 days ago - Why United Community Banks (UCB) is a Great Dividend Stock Right Now - Nasdaq
- 5 weeks ago - UCB Reports 3 Year Data Showing Sustained Benefits Of BIMZELX In Hidradenitis Suppurativa - Nasdaq
- 6 weeks ago - United Community Banks (UCB) Could Be a Great Choice - Nasdaq
- 2 months ago - RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program - Benzinga